Summary
UnitedHealth Group Inc. (UNH) announced a significant leadership change in its finance department via an 8-K filing dated July 31, 2025. Wayne S. DeVeydt has been appointed as the new Chief Financial Officer (CFO), effective September 2, 2025. Mr. DeVeydt brings extensive experience to the role, having previously served as CFO at Elevance Health (formerly Anthem) and held leadership positions at Bain Capital and Surgery Partners. This transition marks a key moment for the company as it integrates a seasoned financial executive into its top finance position, with the current CFO, John F. Rex, moving to a Strategic Advisor role to the CEO. The filing details Mr. DeVeydt's compensation package, which includes a substantial base salary, annual bonus target, and significant stock awards (RSUs, NSOs, and PSUs) designed to align his interests with long-term company performance. The terms of his employment agreement, including sign-on bonuses and severance provisions, have also been disclosed, providing transparency into the financial arrangements for this critical executive hire. Investors should monitor how Mr. DeVeydt's leadership influences the company's financial strategy and execution moving forward.
Key Highlights
- 1Wayne S. DeVeydt appointed Chief Financial Officer (CFO) effective September 2, 2025.
- 2Current CFO, John F. Rex, transitions to Strategic Advisor to the CEO.
- 3Mr. DeVeydt has extensive prior CFO experience at Elevance Health and leadership roles at Bain Capital and Surgery Partners.
- 4New CFO's compensation includes a $1,000,000 annual base salary and a target annual bonus of 200% of base salary.
- 5Significant stock awards for Mr. DeVeydt include initial annual targets of $10,000,000 and a $5,000,000 sign-on stock award.
- 6Employment agreement includes a $1,200,000 sign-on bonus and severance provisions.
- 7Mr. DeVeydt's appointment signifies a strategic move to bolster the company's financial leadership with external expertise.